Could GLP-1 receptor agonists treat addiction and dementia?
Drug Discovery World
AUGUST 21, 2023
It is currently under investigation in various other clinical trials, for example, as a treatment for polycystic ovary syndrome at the University of Hull, and to understand its impact on ageing at the University of Texas Health Science Center at San Antonio. The drugs are currently approved as treatments for type 2 diabetes and weight loss.
Let's personalize your content